Tarsons Products (Small Cap) Share Target 2024, 2025 To 2039
|
Tarsons Products Limited |
|||
|
Price: ₹390.30 | ||
| 52 Week Low: ₹378.00 52 Week High: ₹551.95 |
|||
| Market Capital: 2,278.55 Crore (Smallcap) | |||
| Healthcare -> Medical Instruments & Supplies | |||
Show Table of Contents
Table of Contents
- 1: Approach 1: Technical Analysis Paired With Price Action
- 1.1: Tarsons Products Share Price Target For 2024
- 1.1.1: Tarsons Products Share Price Target Table For 2024
- 1.1.2: Short-Term Technical Outlook
- 1.2: Tarsons Products Share Price Target For 2025
- 1.2.1: Tarsons Products Share Price Target Table For 2025
- 1.2.2: Long-Term Technical Outlook
- 2: Approach 2: Machine Learning By Studying Historical Prices
- 2.1: Tarsons Products Share Price Target Chart and Table From 2024, 2025, 2026 to 2039
- 3: Tarsons Products Brief Company Overview
- 4: Tarsons Products Financial Performance
- 4.0.1: Is Tarsons Products A Good Buy For Long Term?
To predict the Tarsons Products's future market prices, we harnessed 2 dynamic approaches:
Approach 1: Technical Analysis Paired With Price Action
Approach 2: Machine Learning By Studying Historical Prices
Approach 1: Technical Analysis Paired With Price Action
Tarsons Products Share Price Target For 2024
The line chart displays the monthly closing prices of Tarsons Products with a black line. The green line shows three potential target prices for 2024, while the red line indicates three potential Stop Loss levels.
For detailed target and stop loss values for Tarsons Products shares in 2024, see the table below.
Tarsons Products Share Price Target Table For 2024
| Level | Value | Analysis |
|---|---|---|
| 2024 Target 3 | 411.25 (+5.36%) | Price Action: 29 Oct 2024 High |
| 2024 Target 2 | 407.0 (+4.26%) | Price Action: 04 Nov 2024 Low |
| 2024 Target 1 | 402.25 (+3.06%) | Price Action: 01 Apr 2024 Low |
| Current Price | 390.30 | Tarsons Products's share price as of 26 Dec 2024 |
| Stop Loss 1 | 381.95 (-2.14%) | Price Action: 22 Nov 2024 Low |
| Stop Loss 2 | 378.0 (-3.16%) | Price Action: Nov 2024 Low |
| Stop Loss 3 | 366.68 (-6.06%) | Fibonacci Retracement Level 28.20% |
Short-Term Technical Outlook
Current Technical Position: Tarsons Products is displaying bearish momentum trading below key moving averages.
Key Technical Level: The 50-day moving average at ₹412.34 serves as the nearest technical reference point.
Historical Returns: 3-month: -11.62% | 6-month: -21.54% | 1-year: -25.66%
Tarsons Products Share Price Target For 2025
The line chart displays the monthly closing prices of Tarsons Products with a black line. The green line shows three potential target prices for 2025, while the red line indicates three potential Stop Loss levels.
For detailed target and stop loss values for Tarsons Products shares in 2025, see the table below.
Tarsons Products Share Price Target Table For 2025
| Level | Value | Analysis |
|---|---|---|
| 2025 Target 3 | 517.55 (+32.6%) | Price Action: 05 Oct 2023 Low |
| 2025 Target 2 | 512.0 (+31.18%) | Price Action: 11 Oct 2023 Low |
| 2025 Target 1 | 506.7 (+29.82%) | Price Action: 15 Dec 2023 High |
| Current Price | 390.30 | Tarsons Products's share price as of 26 Dec 2024 |
| Stop Loss 1 | 359.65 (-7.86%) | Price Action: Chart |
| Stop Loss 2 | 356.05 (-8.77%) | Price Action: Chart |
| Stop Loss 3 | 349.64 (-10.42%) | Price Action: Chart |
Long-Term Technical Outlook
52-Week Range Analysis: Tarsons Products is currently trading near its 52-week low of ₹378, indicating potential value opportunity.
Long-Term Trend Analysis: The stock is in a bearish long-term trend, trading below key long-term moving averages.
Long-Term Performance: 1-year: -25.66% | 3-year: -39.49% | 5-year: NA
Stay ahead of the market! Get instant alerts on crucial market breakouts. Don't miss out on key opportunities!
Your phone number will be HIDDEN to other users.
Approach 2: Machine Learning By Studying Historical Prices
Tarsons Products Share Price Target Chart and Table From 2024, 2025, 2026 to 2039
| Year | Target 1 | Target 1 YoY Chg % | Target 2 |
|---|---|---|---|
| Current Price | ₹390.30 | ||
| 2024 | ₹396.86 | +1.68% | ₹403.13 |
| 2025 | ₹299.57 | -24.51% | ₹389.46 |
| 2026 | ₹312.29 | +4.24% | ₹318.27 |
| 2027 | ₹342.26 | +9.59% | ₹347.39 |
| 2028 | ₹307.24 | -10.23% | ₹339.06 |
| 2029 | ₹284.27 | -7.47% | ₹303.19 |
| 2030 | ₹283.06 | -0.42% | ₹295.74 |
| 2031 | ₹507.09 | +79.14% | ₹514.70 |
| 2032 | ₹505.03 | -0.4% | ₹512.61 |
| 2033 | ₹505.57 | +0.1% | ₹515.81 |
| 2034 | ₹508.70 | +0.61% | ₹517.02 |
| 2035 | ₹515.56 | +1.34% | ₹523.29 |
| 2036 | ₹526.94 | +2.2% | ₹534.84 |
| 2037 | ₹524.64 | -0.43% | ₹532.51 |
| 2038 | ₹525.06 | +0.08% | ₹535.71 |
| 2039 | ₹536.87 | +2.24% | ₹544.92 |
Note: Target 1 and Target 2 represent price levels that the stock is most likely to achieve during the respective year, based on machine learning algorithms analyzing historical price patterns and market behavior. These predictions are generated through comprehensive analysis of the stock's historical data using advanced ML models.
Tarsons Products Brief Company Overview
Tarsons Products Limited: A Reputable Manufacturer in the Scientific Industry Founded in 1983, Tarsons Products Limited is a leading manufacturer and trader of plastic laboratory products and scientific instruments in India and internationally. With a diverse product range that...
includes disposable plastic labware, centrifuge ware, liquid handling systems, and more, Tarsons has established a strong presence in the industry. The company's products are widely used in fields such as molecular biology, cell culture, genomics, proteomics, and immunology. Tarsons is known for its commitment to innovation and quality, which has earned it a reputation for excellence in the scientific community. Key Products: Disposable plastic labware, centrifuge ware, cryo labware, liquid handling systems, instruments, bottles, measuring cylinders, cell culture products, electrophoresis, microscopy and microbiology products, vacuum desiccators, mini coolers, cryo boxes, test tube racks, PCR products, pipette tips, petri dishes, centrifuge tubes, cryo vials, pasteur pipettes. Market Presence: India and internationally. Reputation: Recognized for innovation and quality in the scientific industry. Commitment: Committed to providing high-quality products and services to its customers.Tarsons Products Financial Performance
| Metric | Value | Description |
|---|---|---|
| Market Capital | 2,278.55 Crore | Market valuation of Tarsons Products's shares. |
| Revenue (TTM) | 272.72 Crore | Total revenue generated by Tarsons Products over the past twelve months. |
| Net Income (TTM) | +55.14 Crore | Net Profit or Loss after all the expenses over the past twelve months. |
| Operating Margin | +20.75% | Income from operations as a percentage of revenue, before taxes and interest. |
| Profit Margin | +20.22% | Net income as a percentage of revenue, after all expenses. |
| Revenue Growth (Quarterly) |
+0.8% | Change in revenue compared to the previous quarter. |
| Earnings Growth (YOY Quarterly) |
-38.4% | Change in earnings compared to the same quarter last year. |
| Debt-to-Equity (D/E) Ratio |
20.79 | Company's total debt divided by total shareholder equity. |
| Total Debt | 122.93 Crore | Sum of Tarsons Products's current & long-term financial obligations. |
| Total Cash | 23.7 Crore | Total amount of liquid funds available to Tarsons Products. |
| Beta | -0.02 | Beta is less than 1 indicating that the Tarsons Products's price is less volatile than the market. |
Is Tarsons Products A Good Buy For Long Term?
Based on the data provided, Tarsons Products stock may not be a good buy for the long term. The company's revenue growth has been flat over the past quarter, and its earnings have declined by 38.4% compared to the same quarter last year. Additionally, the company has a high debt-to-equity ratio and a low cash balance, which could pose financial risks.
Disclaimer: The information provided on this page is for educational purposes only and should not be considered as financial advice. Historical performance data and technical analysis cannot guarantee future results. Stock investments are subject to market risks. Please consult with a qualified financial advisor before making any investment decisions.
All stock data shown is sourced from publicly available information and while we strive for accuracy, we cannot guarantee the absolute accuracy of all figures. Users should verify critical information from official sources before making investment decisions.
